tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TSHA Stock Latest News

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesTaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14d ago
TSHA
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
PremiumThe Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
14d ago
TSHA
Taysha Gene Therapies price target lowered to $6 from $7 at Canaccord
PremiumThe Fly
Taysha Gene Therapies price target lowered to $6 from $7 at Canaccord
1M ago
TSHA
Taysha Gene Therapies reports Q2 revenue $1.112M, consensus $2.66M
PremiumThe Fly
Taysha Gene Therapies reports Q2 revenue $1.112M, consensus $2.66M
1M ago
TSHA
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update
1M ago
TSHA
Options Volatility and Implied Earnings Moves Today, August 12, 2024
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, August 12, 2024
1M ago
DHT
RUM
TSHA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TSHA Upcoming Earnings Report: What to Expect?
1M ago
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2M ago
TSHA
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3M ago
TSHA
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
PremiumThe Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
3M ago
TSHA
Taysha Gene Therapies price target lowered to $7 from $9 at Piper Sandler
PremiumThe Fly
Taysha Gene Therapies price target lowered to $7 from $9 at Piper Sandler
3M ago
TSHA
Taysha Gene Therapies initiated with an Outperform at BMO Capital
PremiumThe Fly
Taysha Gene Therapies initiated with an Outperform at BMO Capital
3M ago
TSHA
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
PremiumPress ReleasesTaysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
3M ago
TSHA
Taysha Gene Therapies 14.361M share Spot Secondary priced at $2.25
Premium
The Fly
Taysha Gene Therapies 14.361M share Spot Secondary priced at $2.25
3M ago
TSHA
Taysha Gene Therapies 14.36M share secondary offering priced at $2.25
Premium
The Fly
Taysha Gene Therapies 14.36M share secondary offering priced at $2.25
3M ago
TSHA
Taysha Gene Therapies falls 12% to $2.16 after filing to sell $75M shares
PremiumThe Fly
Taysha Gene Therapies falls 12% to $2.16 after filing to sell $75M shares
3M ago
TSHA
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
PremiumPress Releases
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
3M ago
TSHA
Taysha Gene Therapies proposes public offering of common stock for up to $75M
PremiumThe Fly
Taysha Gene Therapies proposes public offering of common stock for up to $75M
3M ago
TSHA
Neurogene negative reaction to competitor data ‘overblown,’ says William Blair
PremiumThe Fly
Neurogene negative reaction to competitor data ‘overblown,’ says William Blair
3M ago
NGNE
TSHA
Taysha Gene Therapies Reports Promising Rett Syndrome Trial Results
PremiumCompany AnnouncementsTaysha Gene Therapies Reports Promising Rett Syndrome Trial Results
3M ago
8K
TSHA
Taysha announces ‘low dose cohort data’ from REVEAL trial for Rett syndrome
Premium
The Fly
Taysha announces ‘low dose cohort data’ from REVEAL trial for Rett syndrome
3M ago
TSHA
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
Premium
Press Releases
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome
3M ago
TSHA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >